BiotechTube
Home/Turquoise Biotechnologies/Rebecca Wilcox, DVM
RW

Rebecca Wilcox, DVM

Vice President, Preclinical Development

Turquoise Biotechnologies

Therapeutic Areas

OncologyImmunologyGastroenterologyNeurologyCardiology

Turquoise Biotechnologies Pipeline

DrugIndicationPhase
Turq-101Inflammatory Bowel DiseasePreclinical
Turq-102Colon CancerPreclinical

Leadership Team at Turquoise Biotechnologies

MG
Majid Ghoddusi, PhD
Founder & Chief Executive Officer
View full Turquoise Biotechnologies profile